ArticleFrontiers in pharmacology2013

Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?

Marco Tafani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.